Melinda Telli, MD

Melinda Telli, MD is an assistant professor of medicine in the division of medical oncology at Stanford University School of Medicine with a clinical and research focus in breast cancer.

Dr. Telli's primary research focus is the development of new treatment strategies for triple-negative and BRCA1/2 associated breast cancer. She is interested in the conduct of studies in early-stage breast cancer that incorporate predictive biomarkers of response to therapy and their translation into clinical care. Other interests include the impacts of anti-cancer therapies on the heart, and medical education.

Dr. Telli has served on many American Society of Clinical Oncology committees, currently serves as a Komen Scholar and is a member of the National Comprehensive Cancer Network Breast Cancer Guideline Panel. She is the recipient of a Susan G. Komen for the Cure Translational Postdoctoral Fellowship Award (2008), American Society of Clinical Oncology Young Investigator Award (2009), and Susan G. Komen for the Cure Leadership Award (2015). She is a repeat recipient of the Stanford Division of Oncology Teaching Award (2010, 2012, 2013, 2014).